With demand for its RNA interference meds booming, Alnylam Pharmaceuticals has commenced work to soup up its flagship ...

New findings point to an opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially including those involved in cancer. In everyday life, when things turn out ...

In everyday life, when things turn out the opposite of what you expect, it's usually cause for frustration. In science, it's often the starting point for discovery. That's what happened to a team of ...

Now, a joint research team from Zhejiang University and Fuzhou University has developed a collaborative treatment platform combining a multichannel 3D-printed bioactive scaffold with a small ...